1) Th1 immune response
Th1应答
1.
Regulatory T cells inhibit the development of Th1 immune responses in the early infection with Plasmodium yoelii 17XL
调节性T细胞抑制约氏疟原虫感染小鼠早期Th1应答的建立
2.
Conclusion:The Th1 immune response is dominant in acute infection when mice are infected by toxoplasma.
结论:BALB/c小鼠感染弓形虫后诱导的免疫应答在感染急性期(第1~8天)以Th1应答为主,第9至13天,宿主免疫应答以Th2细胞应答为主,之后Th1/Th2应答基本恢复平衡。
3) Th1 immune response
Th1免疫应答
4) Th2/Th1 reaction
Th1/Th2反应
1.
Subcutaneous injection of PLGA-encapsulated OVA nanoparticles reduces the respiratory inflammation and modifies Th2/Th1 reaction in a mouse asthma model;
PLGA为佐剂的OVA纳米疫苗皮下注射可预防小鼠过敏反应性气道炎症和调节Th1/Th2反应
5) Th1 response
Th1反应
1.
To clarify the Th1 response characteristics of resistant and susceptible mice during the early phase of malaria parasite infection,the levels of IFN-γ and NO in culture supernatants of splenocytes,suspending lymphocytes and macrophages from DBA/2 and BALB/c mice on the third day post-infection were measured.
为探讨疟原虫感染早期抵抗和易感小鼠Th1反应特点,以约氏疟原虫腹腔感染DBA/2和BALB/c小鼠为材料,用ELISA试剂盒和Griess实验分别检测感染第3天小鼠脾细胞、悬浮细胞以及巨噬细胞培养上清液中IFN-γ和NO水平。
6) answer
[英]['ɑ:nsə(r)] [美]['ænsɚ]
回答应答
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条